We are live on
!
Find out more
FA
Fagan Associates Portfolio holdings
AUM
$719M
1-Year Est. Return
26.65%
This Fund
S&P 500
This Quarter
Est. Return
+6.88%
1 Year Est. Return
+26.65%
3 Year Est. Return
+87.69%
5 Year Est. Return
+107.31%
10 Year Est. Return
+467.14%
AUM
$375M
AUM Growth
+$17.3M
(+4.8%)
Cap. Flow
+$572K
Cap. Flow
% of AUM
0.15%
Top 10 Holdings %
Top 10 Hldgs %
39.83%
Holding
126
New
7
Increased
53
Reduced
46
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust Smith Opportunistic Fixed Income ETF
FIXD
|
+$3.1M |
| 2 |
Pfizer
PFE
|
+$2.46M |
| 3 |
iShares Biotechnology ETF
IBB
|
+$1.87M |
| 4 |
KeyCorp
KEY
|
+$1.82M |
| 5 |
Uber
UBER
|
+$1.55M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.81M |
| 2 |
Microsoft
MSFT
|
+$3.59M |
| 3 |
Vanguard Total International Bond ETF
BNDX
|
+$2.83M |
| 4 |
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
|
+$1.46M |
| 5 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$890K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.66% |
| 2 | Consumer Discretionary | 11.73% |
| 3 | Financials | 10.91% |
| 4 | Communication Services | 8.51% |
| 5 | Healthcare | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Apple
AAPL
$4.89T
| $28.7M | 7.64% |
220,619
-26,668
| -11% | -$3.81M |
|
2
Alphabet (Google) Class A
GOOGL
$3.91T
| $22.9M | 6.11% |
259,721
+1,951
| +0.8% | +$185K |
|
|
3
Microsoft
MSFT
$2.84T
| $22.9M | 6.09% |
95,287
-14,954
| -14% | -$3.59M |
|
4
Lowe's Companies
LOW
$116B
| $16.2M | 4.33% |
81,434
-502
| -0.6% | -$100K |
|
|
5
Invesco S&P 500 Equal Weight ETF
RSP
$96.1B
| $11.9M | 3.16% |
83,904
-6,367
| -7% | -$890K |
|
6
Chevron
CVX
$388B
| $10.6M | 2.82% |
58,979
+1,177
| +2% | +$205K |
|
7
Starbucks
SBUX
$118B
| $10.6M | 2.82% |
106,446
+1,344
| +1% | +$127K |
|
8
Qualcomm
QCOM
$176B
| $8.65M | 2.31% |
78,662
+8
| +0% | +$936 |
|
9
JPMorgan Chase
JPM
$939B
| $8.6M | 2.29% |
64,106
-59
| -0.1% | -$7.48K |
|
10
Mastercard
MA
$477B
| $8.46M | 2.26% |
24,340
-37
| -0.2% | -$12.2K |
|
11
Johnson & Johnson
JNJ
$635B
| $8.29M | 2.21% |
46,925
+643
| +1% | +$111K |
|
12
State Street Energy Select Sector SPDR ETF
XLE
$39.5B
| $8.1M | 2.16% |
185,274
+8,416
| +5% | +$366K |
|
13
Nike
NKE
$61.9B
| $8M | 2.13% |
68,411
-262
| -0.4% | -$26.4K |
|
14
Visa
V
$677B
| $7.92M | 2.11% |
38,136
+31
| +0.1% | +$6.25K |
|
15
Vertex Pharmaceuticals
VRTX
$121B
| $7M | 1.87% |
24,241
+250
| +1% | +$76.2K |
|
16
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.1B
| $6.75M | 1.8% |
87,087
-3,944
| -4% | -$303K |
|
17
Advanced Micro Devices
AMD
$851B
| $6.26M | 1.67% |
96,724
+2,435
| +3% | +$161K |
|
18
Amazon
AMZN
$2.5T
| $6.26M | 1.67% |
74,486
+415
| +0.6% | +$41K |
|
19
Occidental Petroleum
OXY
$57B
| $5.95M | 1.59% |
94,470
+1,240
| +1% | +$84.4K |
|
20
Bank of America
BAC
$435B
| $5.92M | 1.58% |
178,717
+869
| +0.5% | +$29.9K |
|
21
JPMorgan Equity Premium Income ETF
JEPI
$45.3B
| $5.82M | 1.55% |
106,855
+331
| +0.3% | +$18K |
|
22
Schwab US TIPS ETF
SCHP
$16.3B
| $5.77M | 1.54% |
222,866
-8,338
| -4% | -$218K |
|
23
Regeneron Pharmaceuticals
REGN
$68.8B
| $5.74M | 1.53% |
7,960
-131
| -2% | -$96.7K |
|
24
Berkshire Hathaway Class B
BRK.B
$1.07T
| $5.7M | 1.52% |
18,452
-66
| -0.4% | -$19.6K |
|
25
Target
TGT
$62.1B
| $5.11M | 1.36% |
34,312
+721
| +2% | +$113K |
|
Similar funds
EI
SAM
KC
TFA
WRPWM
WLIM
NI
CFO
Fagan Associates's Q4 2022 Portfolio in Review
As of Q4 2022, Fagan Associates held 126 positions worth $375M, up 4.8% from $358M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Fagan Associates's Q4 2022 filing shows 7 new, 53 increased, 46 reduced and 4 closed positions. Its largest new stake was First Trust Smith Opportunistic Fixed Income ETF: 70,987 shares worth $3.12M. The largest sale was Apple, an estimated $3.81M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
- Fagan Associates's largest Q4 2022 buy was First Trust Smith Opportunistic Fixed Income ETF: 70,987 shares worth $3.12M.
- Fagan Associates added most to Pfizer in Q4 2022, an estimated $2.46M increase.
- Fagan Associates's biggest Q4 2022 reduction was Apple, cutting an estimated $3.81M.
- Fagan Associates fully exited State Street SPDR Bloomberg Investment Grade Floating Rate ETF in Q4 2022, selling an estimated $1.46M.
- Fagan Associates's ten largest holdings make up 40% of its $375M portfolio in Q4 2022.
- Fagan Associates opened 7 new positions and closed 4 in Q4 2022.
- Fagan Associates's portfolio value rose 4.8% quarter-over-quarter to $375M.
Based on Fagan Associates's 13F filing for Q4 2022, filed 26 Jan 2023.